| Atezolizumab | Tecentriq® | Immunotherapy Immune checkpoint inhibitor (anti-PD-L1) |  | https://www.tecentriq.com/ |
| Atezolizumab/hyaluronidase-tqjs | Tecentriq Hybreza™ | Immunotherapy Immune checkpoint inhibitor (anti-PD-L1) |  | https://www.tecentriq.com/hybreza.html |
| Binimetinib | Mektovi® | Targeted therapy (anti-MEK) Used with encorafenib |  | https://www.braftovi.com/ |
| Cobimetinib | Cotellic® | Targeted therapy (anti-MEK) Used with vemurafenib
| | https://www.gene.com/patients/medicines/cotellic |
| Dabrafenib | Tafinlar® | Targeted therapy (anti-BRAF) Used with trametinib | | https://us.tafinlarmekinist.com/advanced-melanoma |
| Dacarbazine | DTIC-Dome® | Chemotherapy | | https://medlineplus.gov/druginfo/meds/a682750.html |
| Encorafenib | Braftovi® | Targeted therapy (anti-BRAF) Used with binimetinib | | https://www.braftovi.com/https://www.braftovi.com/ |
| Interleukin-2 (IL-2, aldesleukin) | Proleukin® | Immunotherapy | | https://www.proleukin.com/ |
| Ipilimumab | Yervoy® | Immunotherapy Immune checkpoint inhibitor (anti-CTLA-4) | | https://packageinserts.bms.com/medguide/medguide_yervoy.pdf? |
| Lifileucel | Amtagvi® | Immunotherapy T-cell therapy
| | https://www.amtagvi.com/ |
| Nivolumab | Opdivo® | Immunotherapy Immune checkpoint inhibitor (anti-PD-1) | | https://www.opdivo.com/ |
| Nivolumab + hyaluronidase-nhvy | Opdivo Qvantig™ | Immunotherapy Immune checkpoint inhibitor (anti-PD-1) | | https://www.opdivohcp.com/efficacy/subcutaneous-administration |
| Pembrolizumab | Keytruda® | Immunotherapy Immune checkpoint inhibitor (anti-PD-1) | | https://www.keytruda.com/ |
| Relatlimab + nivolumab | Opdualag® | Immunotherapy Immune checkpoint inhibitor (anti-LAG-3 + anti-PD-1) | | https://www.opdualag.com/ |
| Talimogene Laherparapvec (T-VEC) | Imlygic® | Viral therapy | | https://www.imlygic.com/ |
| Trametinib | Mekinist® | Targeted therapy (anti-MEK)Used with dabrafenib) | | https://us.tafinlarmekinist.com/ |
| Vemurafenib | Zelboraf® | Targeted therapy (anti-BRAF) | | https://www.gene.com/patients/medicines/zelboraf |
